Steroids in allergic disease.
From the experience above, it may be concluded that corticosteroid therapy in allergic disease has become more effective than ever before. The expected variations in usage of new important pharmacologic agents is seen with special clarity in the use of corticosteroids. The wide acclaim for the "miracle drug of the 1950's", which followed penicillin of the 1940's, soon gave away to anguish about side-effects that threatened to abolish its use entirely in the late 1950's. The 1960's brought alternate day therapy for chronic usage and recognition that short term usage was relatively safe. The 1970's saw proliferation of topically active steroids similar to those so important to the practice of Dermatology in the previous decade. Results in treating asthma and nasal diseases have been excellent and extensive research for adverse effects has been largely unrevealing.
D000281:Administration, Intranasal; D000305:Adrenal Cortex Hormones / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D001249:Asthma / Q000188:drug therapy; D001507:Beclomethasone / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D002386:Cataract / Q000139:chemically induced; D003480:Cushing Syndrome / Q000139:chemically induced; D006801:Humans; D006967:Hypersensitivity / Q000188:drug therapy*; D006969:Hypersensitivity, Immediate / Q000188:drug therapy; D008134:Long-Term Care; D009298:Nasal Polyps / Q000139:chemically induced; D010020:Osteonecrosis / Q000139:chemically induced; D010024:Osteoporosis / Q000139:chemically induced; D011241:Prednisone / Q000627:therapeutic use; D012220:Rhinitis / Q000188:drug therapy; D007319:Sleep Initiation and Maintenance Disorders / Q000139:chemically induced; D013312:Stress, Physiological / Q000139:chemically induced
D000305:Adrenal Cortex Hormones; D001507:Beclomethasone; D011241:Prednisone